Piper Sandler analyst Jessica Tassan has reiterated an 'Overweight' rating on Cigna Group and increased its price target from $346 to $370. This indicates a positive outlook from the analyst, suggesting potential upside for Cigna's stock based on their valuation models.
This filing discloses that Piper Sandler has maintained its 'Overweight' rating on Cigna Group (CI) and raised its price target from $346 to $370. This analyst action is a positive signal for Cigna, as it suggests that Piper Sandler believes the company's stock has further room to grow. For traders, this could lead to short-term positive sentiment and potentially increased buying activity, as the higher price target implies a more optimistic valuation. Long-term implications depend on Cigna's actual performance and whether it meets or exceeds analyst expectations, but for now, it provides a bullish indicator. The key opportunity for traders is to potentially capitalize on the immediate positive reaction to this analyst upgrade.